OBIO
Price:
$3.99
Market Cap:
$238.92M
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo...[Read more]
Industry
Biotechnology
IPO Date
2020-08-04
Stock Exchange
NASDAQ
Ticker
OBIO
According to Orchestra BioMed Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.20. This represents a change of -928.14% compared to the average of 0.51 of the last 4 quarters.
The mean historical PE Ratio of Orchestra BioMed Holdings, Inc. over the last ten years is -345.18. The current -4.20 PE Ratio has changed 21.68% with respect to the historical average. Over the past ten years (40 quarters), OBIO's PE Ratio was at its highest in in the December 2025 quarter at 6.48. The PE Ratio was at its lowest in in the March 2022 quarter at -179.53.
Average
-345.18
Median
-6.86
Minimum
-1507.06
Maximum
-2.41
Discovering the peaks and valleys of Orchestra BioMed Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.80%
Maximum Annual PE Ratio = -2.41
Minimum Annual Increase = -98.61%
Minimum Annual PE Ratio = -1507.06
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.01 | 24.80% |
| 2024 | -2.41 | -60.94% |
| 2023 | -6.17 | -18.41% |
| 2022 | -7.56 | -98.61% |
| 2021 | -544.86 | -63.85% |
The current PE Ratio of Orchestra BioMed Holdings, Inc. (OBIO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.86
5-year avg
-112.80
10-year avg
-345.18
Orchestra BioMed Holdings, Inc.’s PE Ratio is less than Prelude Therapeutics Incorporated (-4.08), less than Inventiva S.A. (-1.61), less than Caribou Biosciences, Inc. (-1.15), greater than Enanta Pharmaceuticals, Inc. (-4.62), less than Invivyd, Inc. (-2.59), less than Pyxis Oncology, Inc. (-1.55), less than Protara Therapeutics, Inc. (-2.73), less than Tenaya Therapeutics, Inc. (-1.55), greater than Eupraxia Pharmaceuticals Inc. (-6.09), less than Avalo Therapeutics, Inc. (-2.52),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.08 | $245.95M | |
| -1.61 | $185.58M | |
| -1.15 | $162.66M | |
| -4.62 | $293.92M | |
| -2.59 | $128.73M | |
| -1.55 | $128.61M | |
| -2.73 | $153.59M | |
| -1.55 | $121.72M | |
| -6.09 | $216.95M | |
| -2.52 | $166.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchestra BioMed Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orchestra BioMed Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orchestra BioMed Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Orchestra BioMed Holdings, Inc. (OBIO)?
What is the highest PE Ratio for Orchestra BioMed Holdings, Inc. (OBIO)?
What is the 3-year average PE Ratio for Orchestra BioMed Holdings, Inc. (OBIO)?
What is the 5-year average PE Ratio for Orchestra BioMed Holdings, Inc. (OBIO)?
How does the current PE Ratio for Orchestra BioMed Holdings, Inc. (OBIO) compare to its historical average?